Month: February 2016

February 26, 2016, by NCI Staff Credit: National Cancer Institute Patients who miss radiation therapy sessions during cancer treatment have an increased risk of their disease returning, even if they eventually complete their course of radiation treatment, according to a new study. The magnitude of the effect was higher than the researchers anticipated, which they
0 Comments
February 24, 2016, by NCI Staff Zebrafish in the laboratory of Leonard Zon, M.D. Credit: Boston Children’s Hospital / Leonard Zon, M.D. Researchers have created a model of cancer in zebrafish that allows them to capture live images of tumors forming and growing, in some cases from a single cell. Using the model, the researchers
0 Comments
February 22, 2016, by NCI Staff Anatomy of the inside of the brain. Researchers have identified a genetic rearrangement that may drive the development of a rare benign brain tumor in children. The rearrangement, which causes parts of two genes to fuse, may spur the growth of tumors through three distinct biological mechanisms simultaneously, the
0 Comments
February 19, 2016, by NCI Staff NCI’s SEER program recently updated The Status of Cancer, in their Did You Know? video series. Many other new resources are available from NCI. NCI constantly publishes new information on its websites, so periodically we provide updates on new content of interest to the cancer community. New Videos Did
0 Comments
February 17, 2016, by Warren Kibbe, Ph.D. The Titan supercomputer at the U.S. Oak Ridge National Laboratory in Tennessee will be one of several supercomputers used in the NCI-DoE National Strategic Computing Initiative. Credit: Oak Ridge National Laboratory, U.S. Department of Energy Imagine the concentrated power of more than one million laptops working to screen
0 Comments
February 12, 2016, by NCI Staff Three images of a patient with an HPV-positive oropharyngeal tumor (large arrow) that has spread to a nearby lymph node (small arrow). Credit: Oncology/UBM Medica www.theoncologyjournal.com In a new study, researchers have confirmed that infection with human papillomavirus (HPV) 16 precedes the development of some head and neck cancers.
0 Comments
February 11, 2016, by NCI Staff By inhibiting the formation of microtublules (green), eribulin disrupts mitosis, a type of cell division, in tumor cells. Credit: Wikimedia Commons / Afunguy The Food and Drug Administration (FDA) approved eribulin mesylate (Halaven®) on January 28 for some patients with liposarcoma. The approval is for patients whose cancers are advanced
0 Comments
February 10, 2016, by Douglas R. Lowy, M.D. Vice President Biden addresses the first meeting of the Cancer Moonshot Task Force. Credit: White House / Pete Souza Yesterday, the White House released the President’s fiscal year (FY) 2017 Budget Request, which includes $680 million of additional funding for NCI to support the cancer research initiative
0 Comments
When the world quiets down at night, any little sound—like a creaky pipe, or a passing car—can seem earsplitting. But the solution to your less-than-silent nights may actually be more noise. “White noise machines decrease distraction by covering up noises that could keep you awake,” explains Carl Brazil, MD, the director of the Division of
0 Comments
February 8, 2016, by NCI Staff An obese mouse (left) and a mouse of normal weight (right). Credit: Wikimedia Commons Researchers have identified a biological mechanism that may help explain a longstanding association between obesity and an increased risk of colorectal cancer in humans. In mice, the researchers found, the excess intake of calories reduced
0 Comments
February 5, 2016, by NCI Staff Credit: National Cancer Institute Many women cancer survivors have problems with mobility and other physical functioning as a result of persistent peripheral neuropathy caused by chemotherapy treatment, according to a new study. The problems with physical functioning were associated with a substantial increase in the women’s risk for injurious
0 Comments
February 2, 2016, by NCI Staff Noel Brewer, Ph.D. Credit: UNC Lineberger Comprehensive Cancer Center Last week, all 69 NCI-Designated Cancer Centers released a consensus statement on human papillomavirus (HPV) vaccination in the United States. The statement describes the continued low rates of HPV vaccination as “a serious public health threat,” recommends that parents have their children
0 Comments
February 1, 2016, by Barbara Conley, M.D. In August 2015, NCI and the ECOG-ACRIN Cancer Research Group launched NCI-MATCH, the largest, first-of-its-kind precision medicine cancer clinical trial to date. As the trial has progressed, we felt it was a good time to bring the cancer community up to date on the status of NCI-MATCH and,
0 Comments